Mandate

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

October 03, 2025

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).

atNorth HPC AB is a company specializing in high-performance computing (HPC) that provides solutions for large-scale data processing used in advanced research, computer-aided simulations, and AI training. The acquisition is an important part of Advania's ambition to become Northern Europe's most comprehensive HPC and AI service provider.

Vinge’s team consisted of Peter Sundgren, Ulrich Ziche, Robin Sultani and Hanna Stamer (M&A), Simon Söderholm and Johanna Fjellström (employment), Nicklas Thorgerzon and Mathilda Persson (IPR), Eva Fredriksson, Martin Boström and Mario Saad (commercial agreements, IT och GDPR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026